Multiple Sclerosis Fatigue
Neurology·MeSH: Fatigue
Prevalence
120.0 / 100K
Incidence
7.0 / 100K/yr
2 drugs in development·1 company·2 clinical trials
Drug Pipeline by Phase
Phase 2(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Multiple Sclerosis Fatigue?
BioSniper tracks 2 drugs in development for Multiple Sclerosis Fatigue across 1 company.
How many clinical trials target Multiple Sclerosis Fatigue?
There are 2 clinical trials targeting Multiple Sclerosis Fatigue tracked by BioSniper.
What is the prevalence of Multiple Sclerosis Fatigue?
The estimated prevalence of Multiple Sclerosis Fatigue is approximately 120.0 per 100,000 population.
Deep-dive into Multiple Sclerosis Fatigue
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis